Avicenna

Avicenna.AI secures FDA clearance for two healthcare AI solutions

Retrieved on: 
Tuesday, March 26, 2024
Avicenna, Pulmonary embolism, Brain, Algorithm, Radiology, La Ciotat, NCCT, Pelvis, Radiodensity, Stroke, Abdomen, Mortality, Triage, AI, Aortic dissection, CINA, Deep learning, Google Images, Intracranial hemorrhage, Machine learning, Probability, FDA, Physician, Health, Embolism, Food, Medical imaging

La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products. Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.

Key Points: 
  • La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products.
  • Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.
  • CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI to secure FDA clearance, joining its AI solutions for medical emergencies, including automatic detection of intracranial hemorrhage (CINA-ICH), large vessel occlusion (CINA-LVO), aortic dissection (CINA-AD), pulmonary embolism (CINA-PE) from CT-scan imaging.
  • "The clearance of CINA-iPE and CINA-ASPECTS marks a significant milestone in our mission to strive for excellence in advancing patient care.

Avicenna.AI secures FDA clearance for two healthcare AI solutions

Retrieved on: 
Tuesday, March 26, 2024
Avicenna, Pulmonary embolism, Brain, Algorithm, Radiology, La Ciotat, NCCT, Pelvis, Radiodensity, Stroke, Abdomen, Mortality, Triage, AI, Aortic dissection, CINA, Deep learning, Google Images, Intracranial hemorrhage, Machine learning, Probability, FDA, Physician, Health, Embolism, Food, Medical imaging

La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products. Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.

Key Points: 
  • La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products.
  • Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.
  • CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI to secure FDA clearance, joining its AI solutions for medical emergencies, including automatic detection of intracranial hemorrhage (CINA-ICH), large vessel occlusion (CINA-LVO), aortic dissection (CINA-AD), pulmonary embolism (CINA-PE) from CT-scan imaging.
  • "The clearance of CINA-iPE and CINA-ASPECTS marks a significant milestone in our mission to strive for excellence in advancing patient care.

Groundbreaking Study Demonstrates 20-Year Remission in Pemphigus Vulgaris Patients Using IVIg Therapy

Retrieved on: 
Wednesday, January 31, 2024
Ahmad, Research, Science, Pemphigus vulgaris, National academy, Patient, Avicenna, Immune tolerance, Doctor of Science, MPA, PNAS, FRCP, Immunoglobulin therapy, DDF, Admiration

Researchers from Tufts University School of Medicine (Boston, MA) and Sorbonne Université (Paris, France) have demonstrated a remarkable 20-year clinical and serological remission in patients using a defined protocol of intravenous immunoglobulin (IVIg) therapy.

Key Points: 
  • Researchers from Tufts University School of Medicine (Boston, MA) and Sorbonne Université (Paris, France) have demonstrated a remarkable 20-year clinical and serological remission in patients using a defined protocol of intravenous immunoglobulin (IVIg) therapy.
  • Twenty-one patients with confirmed PV received IVIg therapy according to a specific protocol.
  • This long-term remission suggests that IVIg may help restore immune balance and tolerance in PV patients.
  • The pioneering research, offering sustained remission for pemphigus vulgaris patients, highlights the considerable potential of IVIg therapy.

Avicena will showcase the world’s smallest 1Tbps optical transceiver at the SuperComputing Conference 2023 in Denver, CO

Retrieved on: 
Tuesday, November 14, 2023
Semiconductor, Data Management, Technology, Software, Artificial Intelligence, Hardware, Cerberus, Artificial intelligence, LLM, ACM/IEEE Supercomputing Conference, Multimedia, MicroLED, LED, Silicon photonics, Samsung Catalyst Fund, Graphics processing unit, Cerberus Capital Management, Conference, ChatGPT, Memory, HBM, CMOS, AI, Exascale computing, Temperature, Samsung, Processor (computing), Video game, Avicenna

Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating the world’s smallest 1Tbps optical transceiver as part its LightBundleTM multi-Tbps chip-to-chip interconnect technology at the SuperComputing Conference (SC23) in Denver, CO ( https://sc23.supercomputing.org/ ).

Key Points: 
  • Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating the world’s smallest 1Tbps optical transceiver as part its LightBundleTM multi-Tbps chip-to-chip interconnect technology at the SuperComputing Conference (SC23) in Denver, CO ( https://sc23.supercomputing.org/ ).
  • Avicena’s microLED-based LightBundle architecture supports unprecedented throughput, shoreline density and low power, unlocking the performance of processors, memory, and sensors.
  • “At Avicena we are excited to showcase the world’s most compact 1Tbps transceiver in the shape of a 3mm x 4mm CMOS ASIC using our patented microLED optical interface,” says Bardia Pezeshki, Founder and CEO of Avicena.
  • “Optical interconnect technology has the potential to improve chip-to-chip and inter-rack performance,” says Marco Chisari, head of the Samsung Semiconductor Innovation Center.

ConcertAI's TeraRecon Broadens Collaboration with Avicenna.AI to Offer AI-Driven Care Coordination for Pulmonary Embolism and Aortic Disease

Retrieved on: 
Wednesday, November 1, 2023
FDA, Intelligence, Triage, AD, Radiology, PACS, AAA, Rupture, Health, Cardiology, Pulmonary embolism, Thoracic aortic aneurysm, Abdominal aortic aneurysm, PE, TAA, Machine learning, Neurology, Aortic dissection, CINA, Algorithm, Avicenna, Deep learning, Patient, Stenosis, Medical device, EU

Together, they will provide global solutions that leverage artificial intelligence to enhance care coordination and improve patient triage for individuals afflicted with pulmonary embolism (PE) and aortic dissection (AD).

Key Points: 
  • Together, they will provide global solutions that leverage artificial intelligence to enhance care coordination and improve patient triage for individuals afflicted with pulmonary embolism (PE) and aortic dissection (AD).
  • This collaboration aims to expedite clinical decision-making and optimize patient care for these critical medical conditions.
  • "We are excited to empower TeraRecon users worldwide with our groundbreaking AI-driven solutions for the care coordination of pulmonary embolism and aortic dissection," said Cyril Di Grandi, Chief Executive Officer of Avicenna.AI.
  • We eagerly anticipate extending the benefits of our pulmonary embolism and aortic dissection triage tools to the emergency room and beyond."

Avicena demonstrates first microLED based Transceiver IC in 16nm finFET CMOS for chip-to-chip communications at ECOC 2023

Retrieved on: 
Monday, October 2, 2023
Technology, Hardware, Artificial Intelligence, Semiconductor, Graphics processing unit, HBM, LLM, Processor (computing), PD, Xpu Há, Communes of Burundi, ChatGPT, Silicon photonics, Multimedia, ICS, European Conference on Information Retrieval, CMOS, Artificial intelligence, AI, ECOC, Memory, Conference, Video game, Computer data storage, Avicenna

Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating its LightBundleTM multi-Tbps chip-to-chip interconnect technology at the European Conference for Optical Communications (ECOC) 2023 in Glasgow, Scotland ( https://www.ecocexhibition.com/ ).

Key Points: 
  • Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating its LightBundleTM multi-Tbps chip-to-chip interconnect technology at the European Conference for Optical Communications (ECOC) 2023 in Glasgow, Scotland ( https://www.ecocexhibition.com/ ).
  • Today, HBM modules must be co-packaged with GPUs because the GPU-memory electrical interconnect is limited to just a few millimeters in length.
  • Conventional optical interconnects based on VCSELs or Silicon Photonics (SiPh) promise to extend the interconnect reach.
  • By contrast, Avicena’s microLED-based LightBundle interconnects provide much lower power and latency, much higher bandwidth density, and can achieve very low costs.

Avicena Demonstrates Hottest Optical Link at OFC 2023

Retrieved on: 
Tuesday, March 7, 2023
Technology, Wearables, Mobile Technology, Semiconductor, IOT (Internet of Things), Apps, Applications, Satellite, Other Technology, Software, Audio, Video, Networks, 5G, Mobile, Wireless, Batteries, Hardware, Electronic Design Automation, Data Management, Artificial Intelligence, Gallium arsenide, MicroLED, OFC, Memory, Communication, Lighting, Indium phosphide, Marketing, Laser, Optics, Immunity, Gallium nitride, EMI, Architecture, ICS, Conference, Xpu Há, PD, LED, Temperature, CMOS, HPC, Printed circuit board, Avicenna

Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating the world’s highest temperature optical link operating at up to 235°C using its LightBundleTM communication architecture and technology at the Optical Fiber Communication Conference (OFC) 2023 in San Diego, CA ( https://www.ofcconference.org/en-us/home/ ).

Key Points: 
  • Avicena, a privately held company headquartered in Sunnyvale, CA, is demonstrating the world’s highest temperature optical link operating at up to 235°C using its LightBundleTM communication architecture and technology at the Optical Fiber Communication Conference (OFC) 2023 in San Diego, CA ( https://www.ofcconference.org/en-us/home/ ).
  • Over the past three decades, optical links have gradually replaced copper interconnects in many segments of wired communications due to their much longer reach, lower power requirements, lighter weight, and immunity to EMI.
  • Today most optical links use semiconductor edge-emitting lasers or vertical cavity surface-emitting lasers (VCSELs).
  • This is igniting interest among our partners and customers in numerous market segments in the automotive, defense, and aerospace industries.”

Avicena Partners With ams OSRAM to Enable High-Volume Future Production of Ultra-Low Energy Chip-to-Chip Interconnects

Retrieved on: 
Monday, March 6, 2023
Aerospace, Technology, Manufacturing, Semiconductor, Telecommunications, Other Manufacturing, Software, Artificial Intelligence, Networks, Mobile, Wireless, Hardware, DALL-E, MicroLED, OSRAM, Memory, U-JIN Tech Corp., Gallium nitride, Multimedia, IC, Xpu Há, ChatGPT, Ams-OSRAM, CMOS, HPC, Electronics, Computer data storage, Cryptocurrency, Nanosys, Avicenna

Avicena Tech Corp., a privately held company in Sunnyvale, CA, has partnered with ams OSRAM to develop high-volume manufacturing of GaN microLED arrays for its industry-leading LightBundle™ communication architecture.

Key Points: 
  • Avicena Tech Corp., a privately held company in Sunnyvale, CA, has partnered with ams OSRAM to develop high-volume manufacturing of GaN microLED arrays for its industry-leading LightBundle™ communication architecture.
  • Attempts to scale current architectures are running headlong into physical limits leading to slower throughput growth, power-hungry and hard to cool systems.
  • This leverages emerging microLED manufacturing ecosystems, in which ams OSRAM is a major player.
  • “As a global leader in GaN LEDs, we are excited to partner with Avicena to transform these very large and important markets.”

Avicenna.AI launches AI solution for incidental pulmonary embolism detection

Retrieved on: 
Wednesday, February 22, 2023
Health, Deep learning, Google Images, European Congress of Radiology, Incidental, Avicenna, CT, Patient, ECR, Mortality, CINA, FDA, Pathology, Machine learning, Pulmonary embolism, Cancer, Medical Education Number, Medical device, Medical imaging, Radiology

MARSEILLE, France, Feb. 22, 2023 /PRNewswire/ -- Medical imaging AI specialist Avicenna.AI today announced the launch of CINA-iPE, a CE-marked AI tool that analyzes images from chest CT scans for the presence of incidental pulmonary embolism. CINA-iPE is the first tool in CINA Incidental, a new suite of medical imaging solutions from Avicenna.AI that detect unsuspected pathologies on CT scans.

Key Points: 
  • MARSEILLE, France, Feb. 22, 2023 /PRNewswire/ -- Medical imaging AI specialist Avicenna.AI today announced the launch of CINA-iPE, a CE-marked AI tool that analyzes images from chest CT scans for the presence of incidental pulmonary embolism.
  • Incidental pulmonary embolism is a frequent finding on routine CT scans of the chest, but only 25% of incidental emboli are reported at the initial interpretation.
  • Delayed and missed findings are some of the most serious problems in diagnostic imaging, and incidental pulmonary embolism is a significant cause of mortality in the cancer patient population.
  • Pulmonary embolism is a dangerous, life-threatening condition, and with CINA-iPE we hope to increase the number of patients identified with incidental PE and help improve their outcomes."

Avicenna.AI launches AI solution for incidental pulmonary embolism detection

Retrieved on: 
Wednesday, February 22, 2023
Health, Deep learning, Google Images, European Congress of Radiology, Incidental, Avicenna, CT, Patient, ECR, Mortality, CINA, FDA, Pathology, Machine learning, Pulmonary embolism, Cancer, Medical Education Number, Medical device, Medical imaging, Radiology

MARSEILLE, France, Feb. 22, 2023 /PRNewswire/ -- Medical imaging AI specialist Avicenna.AI today announced the launch of CINA-iPE, a CE-marked AI tool that analyzes images from chest CT scans for the presence of incidental pulmonary embolism. CINA-iPE is the first tool in CINA Incidental, a new suite of medical imaging solutions from Avicenna.AI that detect unsuspected pathologies on CT scans.

Key Points: 
  • MARSEILLE, France, Feb. 22, 2023 /PRNewswire/ -- Medical imaging AI specialist Avicenna.AI today announced the launch of CINA-iPE, a CE-marked AI tool that analyzes images from chest CT scans for the presence of incidental pulmonary embolism.
  • Incidental pulmonary embolism is a frequent finding on routine CT scans of the chest, but only 25% of incidental emboli are reported at the initial interpretation.
  • Delayed and missed findings are some of the most serious problems in diagnostic imaging, and incidental pulmonary embolism is a significant cause of mortality in the cancer patient population.
  • Pulmonary embolism is a dangerous, life-threatening condition, and with CINA-iPE we hope to increase the number of patients identified with incidental PE and help improve their outcomes."